Ndonovo Therapeutics Inc (ENDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,543 | -4,939 | -2,413 | -3,105 | -5,501 |
| Depreciation Amortization | 576 | 383 | 192 | 793 | 590 |
| Accounts receivable | N/A | N/A | N/A | 0 | -6 |
| Other Working Capital | 1,692 | 1,142 | 507 | 1,223 | 1,154 |
| Other Operating Activity | 2,822 | 3,085 | 1,591 | 103 | 3,168 |
| Operating Cash Flow | $-453 | $-329 | $-123 | $-987 | $-595 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 400 | 250 | 100 | 950 | 475 |
| Debt Repayment | N/A | N/A | N/A | N/A | -3 |
| Common Stock Issued | N/A | N/A | N/A | 126 | 126 |
| Other Financing Activity | -10 | -7 | -3 | -17 | -10 |
| Financing Cash Flow | $391 | $244 | $97 | $1,059 | $588 |
| Beginning Cash Position | 86 | 86 | 86 | 13 | 13 |
| End Cash Position | 23 | N/A | 60 | 86 | 6 |
| Net Cash Flow | $-63 | $-86 | $-26 | $73 | $-8 |
| Free Cash Flow | |||||
| Operating Cash Flow | -453 | -329 | -123 | -987 | -595 |
| Free Cash Flow | -453 | -329 | -123 | -987 | -595 |